ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Kayla Valigura Wins PCCA’s 2022 International Seminar Pharmacy Student Scholarship Contest

Houston, Oct. 19, 2022 (GLOBE NEWSWIRE) -- PCCA selected pharmacy student Kayla Valigura from the University of Houston College of Pharmacy as the winner of its 2022 International Seminar Pharmacy Student Scholarship Contest. Valigura will deliver a 10-minute main-stage presentation on Saturday, October 29, during International Seminar 2022. This year’s event in Houston is expected draw more than 250 in-person and virtual attendees from the United States, Canada, Australia and beyond.

“Kayla’s compassion for patients will warm your heart,” said PCCA President Jim Smith, “and her commitment to compounding will motivate even the most seasoned compounder. She has incredible drive and is determined to increase awareness about how compounded medicines benefit patients and their doctors.”

Pharmacy students across the country entered the PCCA Institute Student Scholarship Contest for an opportunity to engage with compounding pharmacists from all over the world at International Seminar. Contest participants discussed existing challenges in the compounding industry and their solutions in a written entry and 90-second video pitch. The award recipients will present on these same topics at International Seminar.

Finalist Brittney Reed, Harding University College of Pharmacy, will precede Valigura’s presentation on Saturday, and Holly Seyler, University of Washington School of Pharmacy, will join PCCA Vice President of Public Affairs, Communications, Education and Human Relations Lizzie Harbin to introduce the Public Affairs Panel on Thursday.

“The enthusiasm, passion and fresh ideas from our award winners, as well as all of the contest participants, are inspiring,” Harbin said. “I’m excited to hear their presentations and spend time with these amazing young people!”

PCCA Director of Academic Affairs Bindhu Batra, PharmD, RPh, agrees. “We developed this contest to engage and encourage future compounders, while helping them make lasting connections with experienced compounders. It’s a wonderful opportunity for all involved.”

Held from October 27-29 in Houston, Texas, International Seminar 2022 will also feature keynote presentations from: Ryan Avery, who shares how to hone leadership skills in “Go From A to THE®”; Robert Rakowski, DC, CCN, DACBN, DIBAK, who explores way to overcome the “deadly quartet” in chronic disease; Pamela Smith, MD, MPH, MS, who discusses the relationship between hormones and psychological disorders; and Sarah Zielsdorf, MD, MS, who addresses thyroid disorders. Event registration is still open. For details, visit www.pccainternationalseminar.com.

 

ABOUT PCCA

PCCA supports the creation of personalized medicine and innovative products that make a difference in patients’ lives. As a complete resource for independent compounding pharmacies and health systems, PCCA provides high-quality products, education and support to more than 3,000 pharmacy members throughout the United States, Canada, Australia and other countries around the world. Incorporated in 1981 by a network of pharmacists, PCCA has supported pharmacy compounding for more than 40 years. Building on PCCA’s passion for continuing education, PCCA Institute provides high-quality compounding training to pharmacy students around the country. Learn more at pccarx.com.

Attachment


Kim Speairs, APR, MBA
PCCA
817-729-5064
kspeairs@pccarx.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.56
+0.02 (0.01%)
AAPL  274.61
+0.50 (0.18%)
AMD  209.17
+1.59 (0.77%)
BAC  54.81
-0.52 (-0.94%)
GOOG  307.73
-1.59 (-0.51%)
META  657.15
+9.64 (1.49%)
MSFT  476.39
+1.57 (0.33%)
NVDA  177.72
+1.43 (0.81%)
ORCL  188.65
+3.73 (2.02%)
TSLA  489.88
+14.57 (3.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.